[HTML] from indianjurol.comR Bansal, V Agrawal… - Indian Journal of Urology, 2011 - Medknow Between January 2000 and December 2008, 24 patients underwent retroperitoneal lymph node dissection (RPLND) for the residual masses after chemotherapy. Two patients in 25 to 35 years age group, one with nonseminomatous GCT (NSGCT) and other with seminomatous GCT ... Related articles - All 2 versions
N Lawrentschuk, A Zuniga, AC Grabowksi… - The Journal of …, 2011 - Elsevier We identified 27 men, of whom 17 (63%) had malignancy, including seminoma in 9, teratoma in 3, embryonal lesion in 1, Leydig cell tumor in 3 and carcinoma in situ in 1, and 10 (37%) had benign lesions. Frozen section was accurate, no positive margins were reported and all ... Cited by 1 - Related articles - All 5 versions
[HTML] from 171.66.121.246SE Olofsson, T Tandstad, M Jerkeman… - Journal of Clinical …, 2011 - 171.66.121.246 ... J Clin Oncol 15:594–603. Abstract/FREE Full Text. ↵: Horwich A,; Peckham MJ. (1986) Transient tumor marker elevation following chemotherapy for germcell tumors of the testis. Cancer Treat Rep 70:1329–1331. Medline. ↵: Calvert AH,; Newell DR,; Gumbrell LA,; et al. ... Cited by 1 - Related articles - All 5 versions
BS Carver… - Current Opinion in Oncology, 2011 - journals.lww.com ... The management of metastatic germcelltumor of the testis. Regardless of histology, patients with advanced GCTs are initially treated with platinum-based chemotherapy, according to the International GermCell Cancer Collaborative Group (IGCCCG) risk stratification. ... Related articles - All 4 versions
N Sadeghi, GM Badalato, M Kates… - … Oncology: Seminars and …, 2011 - Elsevier ... The management paradigms for residual, non-RP disease following chemotherapy for nonseminomatous germcelltumor are influenced by the site of metastases as well as whether there is concordant histology between the testicle and the metastatic site. ... Related articles - All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
